NewsBenzingaHC Wainwright & Co. 重申对 Journey Medical 的“买入”评级，并维持 13 美元目标价 HC Wainwright & Co. 重申对 Journey Medical 的“买入”评级，并维持 13 美元目标价 Benzinga 2026.10.26 10:28 (GMT+0) Open on Benzinga Other news Parker-Hannifin Earnings Preview: What to Expect HUYA Q3 2026 Preview: Game-Related Services And Advertising Take The Wheel (NYSE:HUYA) Goldman Sachs Maintains Buy on Allegion, Raises Price Target to $206 Why Adobe Stock Is the Best ‘Anti-AI’ Play This Earnings Season Goldman Sachs Maintains Neutral on Duolingo, Raises Price Target to $135 What You Need to Know Ahead of Ralph Lauren’s Earnings Release
